Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    ES16 - Joint Global Lung Cancer Coalition/IASLC Session: Hot Topics for Advocates

    • 14:15 - 15:15
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Patient Advocacy
    • +

      ES16.01 - Chair

      14:15 - 14:15  |  Presenter: Matthew Peters

      • Abstract

      No abstract available for this presentation

    • +

      ES16.02 - Chair

      14:15 - 14:15  |  Presenter: Satoko Kono Yamaoka

      • Abstract

      No abstract available for this presentation

    • +

      ES16.03 - Pro – New Trend and Tool

      14:15 - 14:27  |  Presenter: Kazuo Hasegawa

      • Abstract

      No abstract available for this presentation

    • +

      ES16.04 - Campaigning for Lung Cancer Screening - A Tool for Advocates

      14:27 - 14:39  |  Presenter: Sarah Elizabeth Winstone

      • Abstract

      Loading...

    • +

      ES16.06 - Insights in Global Lung Cancer Patient Experience

      14:39 - 14:51  |  Presenter: Lillian Leigh

      • Abstract

      Loading...

    • +

      ES16.07 - Live Q&A

      14:51 - 15:15

      • Abstract

      No abstract available for this presentation

  • +

    MA06 - Molecular Developments and Novel Treatments in Mesothelioma and Thymoma

    • 14:15 - 15:15
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      MA06.01 - Chair

      14:15 - 14:15  |  Presenter: Harvey I. Pass

      • Abstract

      No abstract available for this presentation

    • +

      MA06.02 - Chair

      14:15 - 14:15  |  Presenter: Joachim Aerts

      • Abstract

      No abstract available for this presentation

    • +

      MA06.03 - Phosphorylated Ribosomal Protein S6, Correlation With Characteristics and Clinical Outcome in Patients With MPM: Results from ETOP Mesoscape

      14:15 - 14:20  |  Presenter: Isabelle Opitz

      • Abstract

      Loading...

    • +

      MA06.04 - FGF5 Expression in Malignant Pleural Mesothelioma: Impact on Cell Growth, Cisplatin Resistance and Patient Survival

      14:20 - 14:25  |  Presenter: Michael Grusch

      • Abstract

      Loading...

    • +

      MA06.05 - Targeting Anti-Apoptotic Mechanisms in Malignant Pleural Mesothelioma

      14:25 - 14:30  |  Presenter: Ren-Wang Peng

      • Abstract

      Loading...

    • +

      MA06.06 - Intracavitary Cisplatin-Fibrin followed by Irradiation after Lung Sparing Surgery in a Rat Model of Malignant Mesothelioma

      14:30 - 14:35  |  Presenter: Michaela B Kirschner

      • Abstract

      Loading...

    • +

      MA06.07 - Discussant

      14:35 - 14:40  |  Presenter: Rabab Mohamed Gaafar

      • Abstract

      No abstract available for this presentation

    • +

      MA06.08 - A Safety Study of Avelumab plus SBRT in Malignant Mesothelioma

      14:40 - 14:45  |  Presenter: Andreas Rimner

      • Abstract

      Loading...

    • +

      MA06.09 - Preliminary Safety, Efficacy Results of KN046 (Bispecific Anti-PD-L1/CTLA4) in Subjects With Rare Thoracic Tumors

      14:45 - 14:50  |  Presenter: Gary Richardson

      • Abstract

      Loading...

    • +

      MA06.10 - A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA

      14:50 - 14:55  |  Presenter: Margaret Ottaviano

      • Abstract

      Loading...

    • +

      MA06.11 - The Collision of Good Syndrome and Autoimmunity in Thymic Epithelial Tumors

      14:55 - 15:00  |  Presenter: Giovannella Palmieri

      • Abstract

      Loading...

    • +

      MA06.12 - Discussant

      15:00 - 15:05  |  Presenter: Jan Hinrich von der Thüsen

      • Abstract

      No abstract available for this presentation

    • +

      MA06.13 - Live Q&A

      15:05 - 15:15

      • Abstract

      No abstract available for this presentation

  • +

    ES17 - The New WHO Classification of Lung Tumors

    • 15:30 - 16:30
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      ES17.01 - Chair

      15:30 - 15:30  |  Presenter: Ming Sound Tsao

      • Abstract

      Loading...

    • +

      ES17.02 - Chair

      15:30 - 15:30  |  Presenter: Dong-Mei Lin

      • Abstract

      No abstract available for this presentation

    • +

      ES17.03 - Updates in Squamous Cell Carcinoma and Neuroendocrine Tumors of the Lung

      15:30 - 15:42  |  Presenter: Andrew Gordon Nicholson

      • Abstract

      Loading...

    • +

      ES17.04 - Updates in Mesothelioma

      15:42 - 15:54  |  Presenter: Sanja Dacic

      • Abstract

      Loading...

    • +

      ES17.05 - Updates in Lung Adenocarcinoma, Mucinous and Non-mucinous

      15:54 - 16:06  |  Presenter: Keith M Kerr

      • Abstract

      No abstract available for this presentation

    • +

      ES17.06 - Updates in Molecular Pathology and Genomics of Lung Tumors

      16:06 - 16:18  |  Presenter: Yasushi Yatabe

      • Abstract

      Loading...

    • +

      ES17.07 - Live Q&A

      16:18 - 16:30

      • Abstract

      No abstract available for this presentation

  • +

    MA07 - Improving Care for People with Lung Cancer: Decision Making, Survivorship, and New Challenges During COVID-19

    • 15:30 - 16:30
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Patient Advocacy
    • +

      MA07.01 - How Lung Cancer Patients Perceive their Treating Doctors and Engage in medical decision-making: Lessons from Project PRIORITY

      15:30 - 15:35  |  Presenter: Jill Feldman

      • Abstract

      Loading...

    • +

      MA07.02 - Are People with Lung Cancer Satisfied with the Care they Receive? 

      15:35 - 15:40  |  Presenter: Yvonne Nartey

      • Abstract

      Loading...

    • +

      MA07.03 - Current Practice of Lung Cancer Survivorship Care: Is a Care Plan Enough?

      15:40 - 15:45  |  Presenter: Hina Khan

      • Abstract

      Loading...

    • +

      MA07.04 - Breathe Anew: Designing and Testing the Feasibility of a Novel Intervention for Lung Cancer Survivorship

      15:45 - 15:50  |  Presenter: Yogita S Patel

      • Abstract

      Loading...

    • +

      MA07.05 - Survivors from Anti-PD-(L)1 Immunotherapy in NSCLC: Clinical Features, Survival Outcomes and Long-term Toxicities

      15:50 - 15:55  |  Presenter: Melinda Hsu

      • Abstract

      Loading...

    • +

      MA07.06 - Discussant

      15:55 - 16:07  |  Presenter: Haryana M. Dhillon

      • Abstract

      No abstract available for this presentation

    • +

      MA07.07 - Assessing the Impact of the COVID-19 Pandemic on Patient Advocacy and Support Organisations

      16:07 - 16:12  |  Presenter: Matthew Peters

      • Abstract

      Loading...

    • +

      MA07.08 - Needs Assessment of Lung Cancer Patients & Caregivers in the Post-Shelter-in-Place Era in the United States during COVID-19

      16:12 - 16:17  |  Presenter: Jessica Selig

      • Abstract

      Loading...

    • +

      MA07.09 - Lung Cancer Patients Survey Under COVID-19 Epidemic

      16:17 - 16:22  |  Presenter: Kazuo Hasegawa

      • Abstract

      Loading...

    • +

      MA07.10 - Discussant

      16:22 - 16:30  |  Presenter: Amy C. Moore

      • Abstract

      No abstract available for this presentation

  • +

    OA09 - Mesothelioma from Pathogenesis to Therapy

    • 15:30 - 16:30
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      OA09.01 - Chair

      15:30 - 15:30  |  Presenter: Bruce Robinson

      • Abstract

      No abstract available for this presentation

    • +

      OA09.02 - Chair

      15:30 - 15:30  |  Presenter: Steven Kao

      • Abstract

      No abstract available for this presentation

    • +

      OA09.03 - MESOMICS Project: Molecular Characterization of Malignant Pleural Mesothelioma Using a Multi-Omic Approach

      15:30 - 15:40  |  Presenter: Lise Mangiante

      • Abstract

      Loading...

    • +

      OA09.04 - The Course of the Risk of Mesothelioma in Karain Cohort With Erionite Exposure Living in Stockholm: No Erionite Exposure No Mesothelioma

      15:40 - 15:50  |  Presenter: MUZAFFER METINTAS

      • Abstract

      Loading...

    • +

      OA09.05 - Real-World Survival Outcomes of Patients with Malignant Pleural Mesothelioma by Physician’s Choice of First-line Platinum Chemotherapy

      15:50 - 16:00  |  Presenter: Kathleen Claire Kerrigan

      • Abstract

      Loading...

    • +

      OA09.06 - Nivolumab in Recurrent Malignant Pleural Mesothelioma: Real-World Data From Expanded Access Program In The Netherlands

      16:00 - 16:10  |  Presenter: Robert Anton Belderbos

      • Abstract

      Loading...

    • +

      OA09.07 - Discussant

      16:10 - 16:20  |  Presenter: Thomas John

      • Abstract

      No abstract available for this presentation

    • +

      OA09.08 - Live Q&A

      16:20 - 16:30

      • Abstract

      No abstract available for this presentation

  • +

    ES18 - The Future of Immunotherapy in Unresectable Mesothelioma

    • 16:45 - 17:45
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      ES18.01 - Immunotherapy – Current State of Play (Concentrating on Current Data for First Line and Salvage Strategies)

      16:45 - 17:00  |  Presenter: Sanjay Popat

      • Abstract

      Loading...

    • +

      ES18.02 - Molecular Profiling as Biomarker for Checkpoint Inhibitors in Mesothelioma

      17:00 - 17:15  |  Presenter: Nicola Jane Waddell

      • Abstract

      No abstract available for this presentation

    • +

      ES18.03 - Checkpoint Inhibitors – How to Combine and Which Combination is Most Promising

      17:15 - 17:30  |  Presenter: Anna Katherine Nowak

      • Abstract

      No abstract available for this presentation

    • +

      ES18.04 - BAP1 as a Biomarker - Implications for Treatment (Including Immunotherapy)

      17:30 - 17:45  |  Presenter: Michele Carbone

      • Abstract

      No abstract available for this presentation

  • +

    ES19 - Patient-Reported Outcomes, Patient Registries and Real-World Evidence: Learning Directly from Patients

    • 16:45 - 17:45
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Patient Advocacy
    • +

      ES19.01 - Chair

      16:45 - 16:45  |  Presenter: Catherine Holliday

      • Abstract

      No abstract available for this presentation

    • +

      ES19.02 - Chair

      16:45 - 16:45  |  Presenter: Vanessa Beattie

      • Abstract

      No abstract available for this presentation

    • +

      ES19.03 - Understanding the Feasibility of Patient Reported Outcomes

      16:45 - 17:00  |  Presenter: Karla Gough

      • Abstract

      Loading...

    • +

      ES19.04 - Improving Lung Cancer Survival Through Tracking of Patient Reported Outcomes

      17:00 - 17:15  |  Presenter: Massimo Di Maio

      • Abstract

      Loading...

    • +

      ES19.05 - Incorporating Patient Reported Outcomes into the Lung Cancer Registry

      17:15 - 17:30  |  Presenter: Jennifer C. King

      • Abstract

      Loading...

    • +

      ES19.06 - Live Q&A

      17:30 - 17:45

      • Abstract

      No abstract available for this presentation

  • +

    MA08 - Advances in Biomarkers for Immune Checkpoint Blockade and Targeted Therapy in Non Small Cell Lung Carcinoma

    • 16:45 - 17:45
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      MA08.01 - Chair

      16:45 - 16:45  |  Presenter: Keith M Kerr

      • Abstract

      No abstract available for this presentation

    • +

      MA08.02 - Chair

      16:45 - 16:45  |  Presenter: Teh-Ying Chou

      • Abstract

      No abstract available for this presentation

    • +

      MA08.03 - Immunotherapy Alone or with Chemotherapy in Advanced NSCLC? Utility of Clinical Factors and Blood-Based Host Immune Profiling

      16:45 - 16:50  |  Presenter: Wallace Akerley

      • Abstract

      Loading...

    • +

      MA08.04 - LIPI and Outcomes of Durvalumab as Consolidation Therapy after ChRT in Patients with Locally-Advanced NSCLC

      16:50 - 16:55  |  Presenter: Mariona Riudavets

      • Abstract

      Loading...

    • +

      MA08.05 - High Concordance in Scoring PD-L1 in NSCLC Using the Roche Digital Pathology uPath system and PD-L1 Assessment Algorithm

      16:55 - 17:00  |  Presenter: Alexander Haragan

      • Abstract

      Loading...

    • +

      MA08.06 - Stratifying PD-L1 Expression Level Based on Multimodal Genomic Features for the Prediction of Immunotherapy Benefit in NSCLC

      17:00 - 17:05  |  Presenter: Yue Li

      • Abstract

      Loading...

    • +

      MA08.07 - Discussant

      17:05 - 17:10  |  Presenter: Wendy Cooper

      • Abstract

      No abstract available for this presentation

    • +

      MA08.08 - Implementation of Diagnostic Biomarker Testing in Lung Cancer: Real-World Data in Japan

      17:10 - 17:15  |  Presenter: Yasushi Yatabe

      • Abstract

      Loading...

    • +

      MA08.09 - Clinical Management of Lung Adenocarcinoma Patients With HER2 V659E Mutation

      17:15 - 17:20  |  Presenter: Ziqi Jia

      • Abstract

      Loading...

    • +

      MA08.10 - LUNGMAP Master Protocol (LUNGMAP): Concordance Between Plasma ctDNA and Tissue Molecular Analysis

      17:20 - 17:25  |  Presenter: Philip Christopher Mack

      • Abstract

      Loading...

    • +

      MA08.11 - Identification of Clinical Features to Predict the Consistency of Mutational Profiles Obtained From Plasma and Tissue of Advanced NSCLC Patient

      17:25 - 17:30  |  Presenter: Yuansheng Zang

      • Abstract

      Loading...

    • +

      MA08.12 - Discussant

      17:30 - 17:35  |  Presenter: Lukas Bubendorf

      • Abstract

      No abstract available for this presentation

    • +

      MA08.13 - Live Q&A

      17:35 - 17:45

      • Abstract

      No abstract available for this presentation

  • +

    PS02 - Presidential Symposium (Re-Broadcast) (Japanese, Mandarin, Spanish Translation Available)

    • 18:00 - 20:00
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PS02.14 - Chair

      18:00 - 18:00  |  Presenter: Tetsuya Mitsudomi

      • Abstract

      No abstract available for this presentation

    • +

      PS02.01 - Welcome Video

      18:00 - 18:02

      • Abstract

      No abstract available for this presentation

    • +

      PS02.02 - National Lung Cancer Screening Program in Taiwan: The TALENT Study

      18:02 - 18:12  |  Presenter: Pan-Chyr Yang

      • Abstract

      Loading...

    • +

      PS02.03 - Discussant

      18:12 - 18:20  |  Presenter: Ugo Pastorino

      • Abstract

      No abstract available for this presentation

    • +

      PS02.04 - International Tailored Chemotherapy Adjuvant Trial : ITACA Trial. Final Results

      18:20 - 18:30  |  Presenter: Silvia Novello

      • Abstract

      Loading...

    • +

      PS02.05 - Surgical and Clinical Outcomes With Neoadjuvant Atezolizumab in Resectable Stage IB–IIIB NSCLC: LCMC3 Trial Primary Analysis

      18:30 - 18:40  |  Presenter: Jay M. Lee

      • Abstract

      Loading...

    • +

      PS02.06 - Discussant

      18:40 - 18:50  |  Presenter: Shinichi Toyooka

      • Abstract

      No abstract available for this presentation

    • +

      PS02.07 - CodeBreaK 100: Registrational Phase 2 Trial of Sotorasib in KRAS p.G12C Mutated Non-small Cell Lung Cancer

      18:50 - 19:00  |  Presenter: Bob T. Li

      • Abstract

      Loading...

    • +

      PS02.08 - Discussant

      19:00 - 19:08  |  Presenter: Pasi Antero Jänne

      • Abstract

      No abstract available for this presentation

    • +

      PS02.09 - Pembrolizumab Plus Ipilimumab vs Pembrolizumab Plus Placebo as 1L Therapy for Metastatic NSCLC of PD-L1 TPS ≥50%: KEYNOTE-598

      19:08 - 19:18  |  Presenter: Michael Boyer

      • Abstract

      Loading...

    • +

      PS02.10 - Discussant

      19:18 - 19:26  |  Presenter: Yun Fan

      • Abstract

      No abstract available for this presentation

    • +

      PS02.11 - Nivolumab Versus Placebo in Relapsed Malignant Mesothelioma: The CONFIRM Phase 3 Trial

      19:26 - 19:36  |  Presenter: Dean Fennell

      • Abstract

      Loading...

    • +

      PS02.12 - Discussant

      19:36 - 19:44  |  Presenter: Rina Hui

      • Abstract

      No abstract available for this presentation

    • +

      PS02.13 - Live Q&A

      19:44 - 20:00

      • Abstract

      No abstract available for this presentation

  • +

    PL04 - A Vision for Clinical Trials in 2020 and Beyond (Japanese, Mandarin, Spanish Translation Available)

    • 07:00 - 09:00
    • 1/31/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL04.01 - Chair

      07:00 - 07:00  |  Presenter: Heather Wakelee

      • Abstract

      No abstract available for this presentation

    • +

      PL04.02 - Chair

      07:00 - 07:00  |  Presenter: Myung-Ju Ahn

      • Abstract

      No abstract available for this presentation

    • +

      PL04.03 - Evolving Challenges in Drug Development

      07:00 - 07:15  |  Presenter: Bruce E. Johnson

      • Abstract

      Loading...

    • +

      PL04.04 - Implementing New Paradigms for Delivering Radiation Therapy in the Clinic

      07:15 - 07:30  |  Presenter: Billy W Loo

      • Abstract

      Loading...

    • +

      PL04.05 - Uptake of RWD and RWE in Clinical Trial Design

      07:30 - 07:45  |  Presenter: Xiaoyuan Chen

      • Abstract

      No abstract available for this presentation

    • +

      PL04.06 - Diversifying Clinical Trial Inclusion Criteria: Current Challenges and Potential Solutions

      07:45 - 08:00  |  Presenter: Jill Feldman

      • Abstract

      No abstract available for this presentation

    • +

      PL04.07 - Looking Into the Future of Drug Development

      08:00 - 08:15  |  Presenter: Jean Charles Soria

      • Abstract

      No abstract available for this presentation

    • +

      PL04.08 - The Future of Clinical Trials - The Surgical Perspective

      08:15 - 08:30  |  Presenter: Masahiro Tsuboi

      • Abstract

      No abstract available for this presentation

    • +

      PL04.09 - Live Q&A

      08:30 - 09:00

      • Abstract

      No abstract available for this presentation